In particular, the effects on impaired lipid transport from the liver, specifically reduced VLDL-1 levels, are already apparent in the fasting state, suggesting that pronounced insulin resistance may consistently enhance the effect of PNPLA3 148M. Here, PNPLA3 is linked to Insulin resistance.